Systematic Review with Meta-Analysis: Low-Level Alcohol Consumption and the Risk of Liver Cancer
Overview
Affiliations
Background/aims: Multiple meta-analyses and observational studies have reported that alcohol is a risk factor for liver cancer. However, whether there is a safe level of alcohol consumption remains unclear. We performed a systematic review and meta-analysis of the correlation between low-level alcohol consumption and the risk of liver cancer.
Methods: Nested case-control studies and cohort studies involving the general population published prior to July 2019 were searched. In total, 28 publications (31 cohorts) with 4,899 incident cases and 10,859 liver cancer-related deaths were included. The pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated.
Results: Compared with those with low levels of alcohol consumption, moderate and heavy drinkers (≥1 drink/day for females and ≥2 drinks/day for males) had pooled ORs of 1.418 (95% CI, 1.192 to 1.687; p<0.001) for liver cancer incidence and 1.167 (95% CI, 1.056 to 1.290; p=0.003) for liver cancer mortality. The pooled OR for liver disease-related mortality for those with more than low levels of alcohol consumption was 3.220 (95% CI, 2.116 to 4.898; p<0.001) and that for all-cause mortality was 1.166 (95% CI, 1.065 to 1.278; p=0.001). The sensitivity analysis showed that none of the studies had a strong effect on the pooled OR. The Egger test, Begg rank correlation test, and the funnel plot showed no overt indication of publication bias.
Conclusions: Continuous consumption of more than a low-level of alcohol (≥1 drink/day for females and ≥2 drinks/ day for males) is related to a higher risk of liver cancer.
Mackow M, Dziubyna T, Jamer T, Slivinskyi D, Pytrus T, Neubauer K Nutrients. 2024; 16(20).
PMID: 39458499 PMC: 11510335. DOI: 10.3390/nu16203505.
To Drink or Not to Drink? Investigating Alcohol's Impact on Prostate Cancer Risk.
Kaltsas A, Chrisofos M, Symeonidis E, Zachariou A, Stavropoulos M, Kratiras Z Cancers (Basel). 2024; 16(20).
PMID: 39456547 PMC: 11506468. DOI: 10.3390/cancers16203453.
Thongsak N, Chitapanarux T, Chotirosniramit A, Chakrabandhu S, Traisathit P, Nakharutai N Front Public Health. 2024; 12:1389760.
PMID: 39381772 PMC: 11459313. DOI: 10.3389/fpubh.2024.1389760.
Batsaikhan O, Chimed-Ochir O, Kubo T, Jigjidsuren C, Delgermaa V, Purevdagva A Front Oncol. 2024; 14:1381173.
PMID: 39290241 PMC: 11405307. DOI: 10.3389/fonc.2024.1381173.
Cai X, Li X, Liang C, Zhang M, Dong Z, Yu W Sci Rep. 2024; 14(1):9474.
PMID: 38658636 PMC: 11043381. DOI: 10.1038/s41598-024-60122-6.